アップストリームバイオプロセスの世界市場:バイオリアクター/発酵槽、細胞培養製品、フィルター、バイオリアクターアクセサリー、バッグ&コンテナ

【英語タイトル】Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product (Bioreactors, Cell Culture), By Workflow, By Use Type, By Mode (In House, Outsourced), And Segment Forecasts, 2019 - 2026

Grand View Researchが出版した調査資料(GV9NV056)・商品コード:GV9NV056
・発行会社(調査会社):Grand View Research
・発行日:2019年9月
・ページ数:145
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、アップストリームバイオプロセスの世界市場について調査・分析し、市場動向、製品別(バイオリアクター/発酵槽、細胞培養製品、フィルター、バイオリアクターアクセサリー、バッグ&コンテナ、その他)分析、ワークフロー別(培地調製、細胞培養、細胞分離)分析、使用タイプ別(マルチユース、シングルユース)分析、モード別(インハウス、アウトソース)分析、地域別分析、競合動向などを含め次の構成でお届け致します。

・調査手法及び範囲
・エグゼクティブサマリー
・市場動向
・アップストリームバイオプロセスの世界市場:製品別(バイオリアクター/発酵槽、細胞培養製品、フィルター、バイオリアクターアクセサリー、バッグ&コンテナ、その他)
・アップストリームバイオプロセスの世界市場:ワークフロー別(培地調製、細胞培養、細胞分離)
・アップストリームバイオプロセスの世界市場:使用タイプ別(マルチユース、シングルユース)
・アップストリームバイオプロセスの世界市場:モード別(インハウス、アウトソース)
・アップストリームバイオプロセスの世界市場:地域別
・競合動向
【レポートの概要】

The global upstream bioprocessing market size is expected to reach USD 12.60 billion by 2026, expanding at a CAGR of 12.90% during the forecast period, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher’s market presence with the addition of GE Biopharma’s cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Further key findings from the report suggest:

• High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment

• Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment

• Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs

• North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth

• Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
1.1 Upstream Bioprocessing Market: Market Outlook
1.2 Upstream Bioprocessing Market: Segment Outlook
1.3 Upstream Bioprocessing Market: Competitive Insights
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
Chapter 3 Market Variables, Trends& Scope
3.1 Industry Pyramid Analysis
3.2 Penetration & Growth Prospect Mapping for Product, 2018
3.3 Upstream Bioprocessing: Technology Overview
3.4 Upstream Bioprocessing Market: Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising adoption of single-use upstream bioprocessing
3.4.1.2 Commercial success and rising demand for biotherapeutics
3.4.1.3 Rising competition among the market vendors
3.4.2 Market restraint analysis
3.4.2.1 Budget constraints for small & emerging players
3.4.2.2 Operational challenges pertaining to upstream bioprocessing
3.4.3 Market challenges
3.4.3.1 Environmental challenges pertaining to the usage of single-use systems
3.5 Business Environment Analysis: Upstream Bioprocessing Market
3.5.1 Industry analysis – Porter’s
3.5.1.1 Supplier power
3.5.1.2 Buyer power
3.5.1.3 Substitution threat
3.5.1.4 Threat from new entrant
3.5.1.5 Competitive rivalry
3.5.2 Upstream bioprocessing market: SWOT analysis, By factor (political & legal, economic and technological)
3.5.3 Major deals & strategic alliances analysis
3.5.3.1 Agreement
3.5.3.2 Technology collaborations
3.5.3.3 Merger & acquisition
3.5.3.4 Licensing & partnership
3.6 Market Entry Strategies
Chapter 4 Upstream Bioprocessing Market Categorization: Product Estimates & Trend Analysis
4.1 Upstream Bioprocessing Market: Product Movement Analysis
4.2 Bioreactors/ Fermenters
4.2.1 Global bioreactors/ fermenters market, 2015 – 2026 (USD Million)
4.3 Cell Culture Products
4.3.1 Global cell culture products market, 2015 – 2026 (USD Million)
4.4 Filters
4.4.1 Global upstream bioprocessing filters market, 2015 – 2026 (USD Million)
4.5 Bioreactors Accessories
4.5.1 Global bioreactors accessories market, 2015 – 2026 (USD Million)
4.6 Bags & Containers
4.6.1 Global bags & containers market, 2015 – 2026 (USD Million)
4.7 Others
4.7.1 Global other upstream bioprocessing products market, 2015 – 2026 (USD Million)
Chapter 5 Upstream Bioprocessing Market Categorization: Workflow Estimates & Trend Analysis
5.1 Upstream Bioprocessing Market: Workflow Movement Analysis
5.2 Media Preparation
5.2.1 Global media preparation market, 2015 – 2026 (USD Million)
5.3 Cell Culture
5.3.1 Global cell culture market, 2015 – 2026 (USD Million)
5.4 Cell Separation
5.4.1 Global cell separation market, 2015 – 2026 (USD Million)
Chapter 6 Upstream Bioprocessing Market Categorization: Use Type Estimates & Trend Analysis
6.1 Upstream Bioprocessing Market: Use Type Movement Analysis
6.2 Multi-use
6.2.1 Global multi-use upstream bioprocessing market, 2015 – 2026 (USD Million)
6.3 Single-use
6.3.1 Global single-use upstream bioprocessing market, 2015 – 2026 (USD Million)
Chapter 7 Upstream Bioprocessing Market Categorization: Mode Estimates & Trend Analysis
7.1 Upstream Bioprocessing Market: Mode Movement Analysis
7.2 In-house
7.2.1 Global in-house upstream bioprocessing market, 2015 – 2026 (USD Million)
7.3 Outsourced
7.3.1 Global outsourced upstream bioprocessing market, 2015 – 2026 (USD Million)
Chapter 8 Upstream Bioprocessing Market Categorization: Regional Estimates & Trend Analysis, by Product, Workflow, Use Type & Mode
8.1 Upstream Bioprocessing Market Share By Region, 2018 & 2026
8.2 North America
8.2.1 North America upstream bioprocessing market, 2015 – 2026 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.2.2.2 U.S. upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.2.2.3 U.S. upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.2.2.4 U.S. upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.2.3 Canada
8.2.3.1 Canada upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.2.3.2 Canada upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.2.3.3 Canada upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.2.3.4 Canada upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.3 Europe
8.3.1 Europe upstream bioprocessing market, 2015 – 2026 (USD Million)
8.3.2 Germany
8.3.2.1 Germany upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.3.2.2 Germany upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.3.2.3 Germany upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.3.2.4 Germany upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.3.3 France
8.3.3.1 France upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.3.3.2 France upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.3.3.3 France upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.3.3.4 France upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific upstream bioprocessing market, 2015 – 2026 (USD Million)
8.4.2 China
8.4.2.1 China upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.4.2.2 China upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.4.2.3 China upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.4.2.4 China upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.4.3 India
8.4.3.1 India upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.4.3.2 India upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.4.3.3 India upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.4.3.4 India upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.5 Latin America
8.5.1 Latin America upstream bioprocessing market, 2015 – 2026 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.5.2.2 Brazil upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.5.2.3 Brazil upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.5.2.4 Brazil upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa upstream bioprocessing market, 2015 – 2026 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa upstream bioprocessing market, by product, 2015 – 2026 (USD Million)
8.6.2.2 South Africa upstream bioprocessing market, by workflow, 2015 – 2026 (USD Million)
8.6.2.3 South Africa upstream bioprocessing market, by use-type, 2015 – 2026 (USD Million)
8.6.2.4 South Africa upstream bioprocessing market, by mode, 2015 – 2026 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Categorization
9.2 Recent Developments & Impact Analysis, by Key Market Participants
9.3 Public Companies
9.3.1 Company market position analysis
9.4 Private Companies
9.4.1 List of key emerging companies/ innovators
9.5 Strategy Framework
9.6 Company Profiles
9.6.1 GE Healthcare
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic initiatives
9.6.2 Thermo Fisher Scientific Inc.
9.6.2.1 Company overview
9.6.2.2 Finesse
9.6.2.2.1 Company overview
9.6.2.3 Patheon
9.6.2.3.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 Merck KGaA
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic initiatives
9.6.4 Corning, Inc.
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic initiatives
9.6.5 Sartorius AG
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic initiatives
9.6.6 Eppendorf AG
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic initiatives
9.6.7 Danaher Corporation
9.6.7.1 Company overview
9.6.7.2 Pall Corporation
9.6.7.2.1 Company overview
9.6.7.3 Financial performance
9.6.7.4 Product benchmarking
9.6.7.5 Strategic initiatives
9.6.8 Boehringer Ingelheim GmbH
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 Applikon Biotechnology
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 PBS Biotech, Inc.
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Lonza
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.12 CellGenix GmbH
9.6.12.1 Company overview
9.6.12.2 Financial performance
9.6.12.3 Product benchmarking
9.6.12.4 Strategic initiatives
9.6.13 Samsung BioLogics
9.6.13.1 Company overview
9.6.13.2 Financial performance
9.6.13.3 Product benchmarking
9.6.13.4 Strategic initiatives
9.6.14 AGC Inc.
9.6.14.1 Company overview
9.6.14.2 CMC Biologics
9.6.14.2.1 Company overview
9.6.14.3 Financial performance
9.6.14.4 Product benchmarking
9.6.14.5 Strategic initiatives
9.6.15 VWR International, LLC
9.6.15.1 Company overview
9.6.15.2 JM BIOCONNECT
9.6.15.2.1 Company overview
9.6.15.3 Financial performance
9.6.15.4 Product benchmarking
9.6.15.5 Strategic initiatives

List of Tables

TABLE 1 North America upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 2 North America upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 3 North America upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 4 North America upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 5 U.S. upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 6 U.S. upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 7 U.S upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 8 U.S. upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 9 Canada upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 10 Canada upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 11 Canada upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 12 Canada upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 13 Europe upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 14 Europe upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 15 Europe upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 16 Europe upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 17 Germany upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 18 Germany upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 19 Germany upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 20 Germany upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 21 France upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 22 France upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 23 France upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 24 France upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 25 Single-use technology landscape in Asian countries
TABLE 26 Asia Pacific upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 27 Asia Pacific upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 28 Asia Pacific upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 29 Asia Pacific upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 30 China upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 31 China upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 32 China upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 33 China upstream bioprocessing market market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 34 India upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 35 India upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 36 India upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 37 India upstream bioprocessing market market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 38 Latin America upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 39 Latin America upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 40 Latin America upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 41 Latin America upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 42 Brazil upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 43 Brazil upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 44 Brazil upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 45 Brazil upstream bioprocessing market market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 46 MEA upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 47 MEA upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 48 MEA upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 49 MEA upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 50 South Africa upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
TABLE 51 South Africa upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
TABLE 52 South Africa upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
TABLE 53 South Africa upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
TABLE 54 List of private companies

【レポートのキーワード】

アップストリームバイオプロセス、バイオリアクター/発酵槽、細胞培養製品、フィルター、バイオリアクターアクセサリー、バッグ&コンテナ、培地調製、細胞培養、細胞分離、マルチユース、シングルユース、インハウス、アウトソース

★調査レポート[アップストリームバイオプロセスの世界市場:バイオリアクター/発酵槽、細胞培養製品、フィルター、バイオリアクターアクセサリー、バッグ&コンテナ] (コード:GV9NV056)販売に関する免責事項を必ずご確認ください。
★調査レポート[アップストリームバイオプロセスの世界市場:バイオリアクター/発酵槽、細胞培養製品、フィルター、バイオリアクターアクセサリー、バッグ&コンテナ]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆